3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Myelodysplastic Syndromes
41
Leukemia, Lymphocytic, Chronic, B-Cell
30
Lymphoma, Non-Hodgkin
27
Multiple Myeloma
22
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Hodgkin Disease
20
Leukemia
17
Myeloproliferative Disorders
16
Recurrence
15
Lymphoma, Follicular
15
Leukemia, Biphenotypic, Acute
15
Melanoma
14
Lymphoma, Mantle-Cell
14
Lymphoma
14
Leukemia, Myelomonocytic, Chronic
14
Lymphoma, Large B-Cell, Diffuse
13
Hematologic Neoplasms
13
Burkitt Lymphoma
11
Anemia, Refractory, with Excess of Blasts
11
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Primary Myelofibrosis
8
Neoplasm, Residual
7
Neoplasm Metastasis
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Neoplasms
6
Graft vs Host Disease
6
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Platinum
6
Cyclophosphamide
6
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
atezolizumab
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
fludarabine phosphate
×
1 year
×
Clear all
No trials found.